Yang, Yang
Peng, Nianchun
Chen, Gang
Wan, Qin
Yan, Li
Wang, Guixia
Qin, Yingfen
Luo, Zuojie
Tang, Xulei
Huo, Yanan
Hu, Ruying
Ye, Zhen
Qin, Guijun
Gao, Zhengnan
Su, Qing
Mu, Yiming
Zhao, Jiajun
Chen, Lulu
Zeng, Tianshu
Yu, Xuefeng
Li, Qiang
Shen, Feixia
Chen, Li
Zhang, Yinfei
Wang, Youmin
Deng, Huacong
Liu, Chao
Wu, Shengli
Yang, Tao
Li, Mian
Xu, Yu
Xu, Min
Zhao, Zhiyun
Wang, Tiange
Lu, Jieli
Bi, Yufang
Wang, Weiqing
Ning, Guang
Zhang, Qiao
Shi, Lixin http://orcid.org/0000-0002-0389-2732
Funding for this research was provided by:
Shanghai Key Laboratory for Endocrine Tumors, National Key R&D Program of China (2016YFC1305600, 2016YFC1305202, 2016YFC1304904, 2017YFC1310700, 2017YFC1309804, 2017YFC1309805, 2018YFC1311705, 2018YFC1311800)
Special Precision Medicine Project of the National Key R&D Program from the Science and Technology Ministry China (2016YFC0901203)
Special Scientific Research Fund of Public Welfare Profession from the National Health and Family Planning Commission of PRC (201502007)
Key Clinical Specialty Cultivation Project of Guizhou Province (SZD-2016-01)
Article History
Received: 14 October 2021
Accepted: 8 January 2022
First Online: 24 January 2022
Declarations
:
: This study was approved by the Medical Ethics Committee of Ruijin Hospital, Shanghai Jiao Tong University. All study participants provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.